Bloomage BioTechnology Corporation Limited

Equities

688363

CNE100003NL9

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
58.77 CNY +1.01% Intraday chart for Bloomage BioTechnology Corporation Limited +7.60% -12.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023. CI
Bloomage Biotech Names CFO MT
Bloomage Biotechnology's 2023 Profit Falls 39.5%; Misses EPS Estimates MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Bloomage Buys Back 8.4 Million Yuan Shares MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Bloomage BioTechnology Corporation Limited announces an Equity Buyback for CNY 300 million worth of its shares. CI
Bloomage BioTechnology Corporation Limited authorizes a Buyback Plan. CI
Chinese company earnings reveal lopsided economic recovery RE
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bloomage Biotech Showcases Cutting-Edge Bioactive Ingredients at International Consumer Products Expo, Expands Global Reach CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yongtaiyun Chemical Logistics to Buy Local Chemical Producer For 50 Million Yuan MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Bloomage BioTechnology Corporation Limited(XSSC:688363) added to S&P Global BMI Index CI
Bloomage Biotechnology to Absorb, Merge With Subsidiary MT
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Bloomage BioTechnology Corporation Limited(SHSE:688363) dropped from Shanghai Stock Exchange Health Care Sector Index CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Bloomage BioTechnology Corporation Limited, entered into a property rights transaction contract to acquire 51% of Beijing Yierkang Bioengineering Co., Ltd., for CNY 233 million. CI
Bloomage BioTechnology Corporation Limited(XSSC:688363) added to FTSE All-World Index CI
Bloomage BioTechnology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Bloomage BioTechnology Corporation Limited(SHSE:688363) added to Shanghai Stock Exchange 180 Value Index CI
Bloomage BioTechnology Corporation Limited(SHSE:688363) added to SSE 180 Index CI
Chart Bloomage BioTechnology Corporation Limited
More charts
Bloomage Biotechnology Corp Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of hyaluronic acid and other bioactive products. The Company's products include raw material products, medical end products, functional skin care products and functional foods. The raw material products include a series of bioactive products with hyaluronic acid as the core, which are widely used in the fields of drugs, medical devices, cosmetics, functional food and general food. The medical end products are divided into medical beauty and medicine, including ophthalmic viscoelastics, medical lubricants, soft tissue fillers, medical skin protectors and others. The functional skin care products include lotion, cream, facial mask, hand mask and others. The functional foods include hyaluronic acid water, hyaluronic acid food and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
58.77 CNY
Average target price
83.72 CNY
Spread / Average Target
+42.45%
Consensus
  1. Stock Market
  2. Equities
  3. 688363 Stock
  4. News Bloomage BioTechnology Corporation Limited
  5. Bloomage Biotechnology to Absorb, Merge With Subsidiary